E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/12/2024 in the Prospect News Bank Loan Daily and Prospect News Distressed Debt Daily.

S&P snips Pathway Vet Alliance

S&P said it lowered its ratings on Pathway Vet Alliance LLC (Thrive Pet Healthcare) and its senior secured credit facility to CCC+ from B-. The 3 recovery rating (rounded estimate: 50%) is unchanged.

The downgrade indicates that, despite some margin improvement, Thrive will keep having free cash flow deficits through 2025 and, potentially, 2026, the agency said.

“Due to our expectation for continued compressed margins, we now forecast Thrive will report a free cash flow deficit of $90 million-$100 million in 2023, which will improve to a deficit of $60 million-$80 million in 2024. We expect the company will be able to cut back on its capital expenditure (capex) in 2025 following the end of its previously contracted projects in 2024. This, coupled with our forecast for a slight improvement in its margins, leads us to expect that Thrive will generate a free cash flow deficit of just $10 million-$30 million by 2025,” S&P said in a press release.

The outlook is negative.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.